Vijaya Diagnostic Centre Limited (VIJAYA.NS)
INR 1059.9
(-1.03%)
INR 1059.9
(-1.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.62 Billion INR | 36.24% |
| 2022 | 1.2 Billion INR | -20.33% |
| 2021 | 1.51 Billion INR | 30.72% |
| 2020 | 1.15 Billion INR | 38.43% |
| 2019 | 834.51 Million INR | 21.77% |
| 2018 | 685.33 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 446.03 Million INR | -4.72% |
| 2023 Q1 | 356.48 Million INR | -15.66% |
| 2023 Q4 | 468.12 Million INR | 9.18% |
| 2023 Q3 | 428.74 Million INR | -14.98% |
| 2023 FY | 1.63 Billion INR | 36.24% |
| 2023 Q2 | 504.28 Million INR | 41.46% |
| 2022 Q4 | 422.69 Million INR | 53.38% |
| 2022 FY | 1.2 Billion INR | -20.33% |
| 2022 Q3 | 275.58 Million INR | -23.75% |
| 2022 Q2 | 361.42 Million INR | 40.54% |
| 2022 Q1 | 257.17 Million INR | -21.05% |
| 2021 Q3 | 348.22 Million INR | -9.95% |
| 2021 FY | 1.51 Billion INR | 30.72% |
| 2021 Q4 | 325.75 Million INR | -6.45% |
| 2021 Q2 | 386.7 Million INR | -13.94% |
| 2021 Q1 | 449.34 Million INR | 1.34% |
| 2020 Q3 | 369.12 Million INR | -7.47% |
| 2020 Q1 | 22.06 Million INR | 0.0% |
| 2020 FY | 1.15 Billion INR | 38.43% |
| 2020 Q4 | 443.39 Million INR | 20.12% |
| 2020 Q2 | 398.94 Million INR | 1708.46% |
| 2019 FY | 834.51 Million INR | 21.77% |
| 2018 FY | 685.33 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 711.88 Million INR | -409.711% |
| Dr. Lal PathLabs Limited | 8.65 Billion INR | 58.076% |
| Metropolis Healthcare Limited | 2.05 Billion INR | -76.539% |
| Thyrocare Technologies Limited | 917 Million INR | -295.696% |
| Vimta Labs Limited | 1.22 Billion INR | -195.644% |